Table: Kaken Pharmaceutical - 6-MTH group results

KAKEN PHARMACEUTICAL

06/11/2017 04:30

Nov 6 (Reuters)-  
             Kaken Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             49.86               52.18           101.70     
                 (-4.4 pct)          (-5.1 pct)       (+0.2 pct)   
  Operating         15.34               16.12            26.80     
                 (-4.9 pct)          (-12.6 pct)      (-12.7 pct)  
  Recurring         15.52               16.24            27.00     
                 (-4.4 pct)          (-12.6 pct)      (-12.9 pct)  
  Net               10.87               11.45            19.10     
                 (-5.1 pct)          (-8.3 pct)       (-13.2 pct)  
  EPS            267.56 yen          278.02 yen       473.70 yen   
  Ann Div                            150.00 yen       150.00 yen   
  -Q2 div         75.00 yen           75.00 yen                    
  -Q4 div                             75.00 yen        75.00 yen   
   
  NOTE - Kaken Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T  
  ((Tokyo Headline News Desk +813 6441 1812))